Site: |
University of Pittsburgh Cancer Institute |
|||
Address: |
||||
City: |
Pittsburgh |
|||
State: |
PA |
|||
Zip: |
15232 |
|||
Country: |
USA |
3 |
Unknown |
Active |
Masitinib, (AB1010) |
NCT00812240 |
|
3 |
Terminated |
Closed |
Imatinib |
NCT01031628 |
|
3 |
Recruiting |
Active |
Bezuclastinib plus Sunitinib |
NCT05208047 |
|
1 |
Recruiting |
Active |
neoBOMB1 |
NCT03872778 |
|
1 |
Recruiting |
Not yet activated |
NB003 |
NCT04936178 |
|
0 |
Recruiting |
Active |
MAAT |
NCT04879979 |
|
2 |
Ongoing, but not recruiting |
Closed |
Dasatinib (BMS-354825) |
NCT00464620 |
|
2 |
Ongoing, but not recruiting |
Closed |
AZD6244 plus Temsirolimus |
NCT01206140 |
|
3 |
Completed |
Closed |
Nilotinib or Imatinib |
NCT00785785 |
|
2 |
Completed |
Active |
Rogaratinib |
NCT04595747 |
|
3 |
Active, not recruiting |
Active |
Avapritinib or Regorafenib |
NCT03465722 |
|
2 |
Active, not recruiting |
Closed |
CB-839 |
NCT03872427 |